Protectival’s Research Presented At The SIO Conference

Last months we were honored to be invited and take part in the Annual Conference of the Society for Integrative Oncology. 

The Society for Integrative Oncology (SIO) is the premier multi-disciplinary professional organization for integrative oncology and its mission is to advance evidence-based, comprehensive, integrative healthcare to improve the lives of people affected by cancer.

LifeBiotic was invited to present the scientific research made on Protectival (Research name LCS101) which was done in collaboration with oncologist from 7 hospitals and universities including MD Anderson and Harvard Medical School.

The conference, co-hosted this year by Memorial Sloan Kettering Cancer Center, and took place at New York. It is the leading integrative oncology event and an exceptional opportunity to learn about new findings in integrative oncology from healthcare/scientific disciplines that have the potential to transform cancer care internationally.

Dr. Yair Maimon Lifebiotic’s Chief Scientist was presenting the research on stage, sharing the process and results of our clinical and pre-clinical studies.

Following our presentation last year to the UNESCO medical community this is yet another important recognition by the healthcare community of our comprehensive and outstanding research on Protectival (LCS101) and an important milestone for LifeBiotic in becoming a trusted evidence-based natural products brand.